Ana Godec
Research Assistant at Department of Pharmacy; Biopharmaceuticals; ProDDe
- E-mail:
- ana.godec@uu.se
- Visiting address:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postal address:
- Box 580
751 23 UPPSALA
Download contact information for Ana Godec at Department of Pharmacy; Biopharmaceuticals; ProDDe

Publications
Recent publications
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Download full text (pdf) of Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
Updated transient gene expression protocol in Expi293F cells using PEI
Part of Frontiers in Bioengineering and Biotechnology, 2025
- DOI for Updated transient gene expression protocol in Expi293F cells using PEI
- Download full text (pdf) of Updated transient gene expression protocol in Expi293F cells using PEI
-
Part of Neurotherapeutics, 2025
- DOI for Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
- Download full text (pdf) of Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
-
Part of Scientific Reports, 2024
- DOI for A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Download full text (pdf) of A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
Part of PLOS ONE, 2024
- DOI for A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
- Download full text (pdf) of A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
All publications
Articles in journal
-
Part of Biomedicine and Pharmacotherapy, 2025
- DOI for Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
- Download full text (pdf) of Somatostatin therapy, neprilysin activation, and amyloid beta reduction: A novel approach for Alzheimer's treatment
-
Updated transient gene expression protocol in Expi293F cells using PEI
Part of Frontiers in Bioengineering and Biotechnology, 2025
- DOI for Updated transient gene expression protocol in Expi293F cells using PEI
- Download full text (pdf) of Updated transient gene expression protocol in Expi293F cells using PEI
-
Part of Neurotherapeutics, 2025
- DOI for Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
- Download full text (pdf) of Lowering the affinity of single-chain monovalent BBB shuttle scFc-scFv8D3 prolongs its half-life and increases brain concentration
-
Part of Scientific Reports, 2024
- DOI for A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
- Download full text (pdf) of A shorter linker in the bispecific antibody RmAb158-scFv8D3 improves TfR-mediated blood-brain barrier transcytosis in vitro
-
A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
Part of PLOS ONE, 2024
- DOI for A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
- Download full text (pdf) of A charged tail on anti-α-Synuclein antibodies does not enhance their affinity to α-Synuclein fibrils
-
Part of Alzheimer's Research & Therapy, 2022
- DOI for Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease
- Download full text (pdf) of Blood-brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease